000 01406 a2200409 4500
005 20250513004504.0
264 0 _c19820614
008 198206s 0 0 eng d
022 _a0312-5963
024 7 _a10.2165/00003088-198207020-00002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAbernethy, D R
245 0 0 _aPharmacokinetics of drugs in obesity.
_h[electronic resource]
260 _bClinical pharmacokinetics
_c
300 _a108-24 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAcetaminophen
_xmetabolism
650 0 4 _aAminoglycosides
_xmetabolism
650 0 4 _aAntipyrine
_xmetabolism
650 0 4 _aBiotransformation
650 0 4 _aDesipramine
_xmetabolism
650 0 4 _aDiazepam
_xmetabolism
650 0 4 _aDigoxin
_xmetabolism
650 0 4 _aEnflurane
_xmetabolism
650 0 4 _aHalf-Life
650 0 4 _aHalothane
_xmetabolism
650 0 4 _aHumans
650 0 4 _aObesity
_xmetabolism
650 0 4 _aPharmaceutical Preparations
_xmetabolism
650 0 4 _aProtein Binding
650 0 4 _aSulfobromophthalein
_xmetabolism
650 0 4 _aTheophylline
_xmetabolism
650 0 4 _aTissue Distribution
700 1 _aGreenblatt, D J
773 0 _tClinical pharmacokinetics
_gvol. 7
_gno. 2
_gp. 108-24
856 4 0 _uhttps://doi.org/10.2165/00003088-198207020-00002
_zAvailable from publisher's website
999 _c7039588
_d7039588